While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

WEDNESDAY, Feb. 5, 2025 (HealthDay News) -- Hopes that GLP-1 drugs such as Ozempic and Wegovy could help slow Parkinson's ...

There is no record of Denmark announcing the tariff on Ozempic exports. The social media user who first shared the claim ...

Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...

Actress and comedian Amy Schumer said she took Ozempic three years ago and quickly lost 30 lbs. However, she quit the ...

These compounds take a different approach to weight loss than existing medications, which can cause nausea, vomiting and ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the ...

Novo Nordisk A/S expects sales to surge again this year as the Danish drugmaker builds supply for blockbuster diabetes ...

Surgical patients may still have leftovers in their system even after a standard fast, potentially increasing the chance of a ...

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...